Transfected Plasmodium knowlesi produces bioactive host gamma interferon: A new perspective for modulating immune responses to malaria parasites

Infection and Immunity

Volumn 71, Issue 8, 2003, Pages 4375-4381

  Ozwara, Hastings ^a,c   Langermans, Jan A M ^a   Kocken, Clemens H M ^a   Van der Wel, Annemarie ^a   Van der Meide, Peter H ^b   Vervenne, Richard A W ^a   Mwenda, Jason M ^c   Thomas, Alan W ^a  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c INSTITUTE OF PRIMATE RESEARCH   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; CYTOKINE; DNA; GAMMA INTERFERON; MEMBRANE ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENE CONSTRUCT; GENE CONTROL; GENETIC TRANSFECTION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; MALARIA; PARASITE DEVELOPMENT; PLASMODIUM KNOWLESI; PRIORITY JOURNAL; PROMOTER REGION; PROTECTION; RHESUS MONKEY;

ANIMALS; BASE SEQUENCE; CELL LINE; CYTOPATHOGENIC EFFECT, VIRAL; DNA, PROTOZOAN; HOST-PARASITE RELATIONS; HUMANS; INTERFERON-GAMMA, RECOMBINANT; MACACA MULATTA; MALARIA; PLASMODIUM BERGHEI; PLASMODIUM KNOWLESI; PROMOTER REGIONS (GENETICS); TRANSFECTION;

EID: 0042766403     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.8.4375-4381.2003     Document Type: Article

References (55)

1. Arakawa, T., Y. R. Hsu, D. Chang, N. Stebbing, and B. Altrock. 1986. Structure and activity of glycosylated human interferon-gamma. J. Interferon Res. 6:687-695.
2. Bienzle, U., K. G. Fritsch, G. Hoth, E. Rozdzinski, K. Kohler, M. Kalinowski, P. Kremsner, F. Rosenkaimer, and H. Feldmeier. 1988. Inhibition of Plasmodium vinckei-malaria in mice by recombinant murine interferon-gamma. Acta Trop. 45:289-290.
3. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15:749-795.
4. Braun-Breton, C., T. L. Rosenberry, and L. P. da Silva. 1988. Induction of the proteolytic activity of a membrane protein in Plasmodium falciparum by phosphatidyl inositol-specific phospholipase C. Nature 332:457-459.
5. Butcher, G. A. 1996. Models for malaria: nature knows best. Parasitol. Today 12:378-382.
6. Cantell, K., S. Hirvonen, L. Pyhala, A. De Reus, and H. Schellekens. 1983. Circulating interferon in rabbits and monkeys after administration of human gamma interferon by different routes. J. Gen. Virol. 64:1823-1826.
7. Chin, W., P. G. Contacos, and G. R. Coatney. 1965. A naturally acquired quotidian-type malaria in man transferable to monkey. Science 149:865.
8. Clark, I. A., N. H. Hunt, G. A. Butcher, and W. B. Cowden. 1987. Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole. J. Immunol. 139:3493-3496.
9. Curls, J. H., P. H. van der Meide, A. Billiau, J. H. Meuwissen, and W. M. Eling. 1993. Plasmodium berghei: recombinant interferon-gamma and the development of parasitemia and cerebral lesions in malaria-infected mice. Exp. Parasitol. 77:212-223.
10. de Koning-Ward, T. F., M. A. Speranca, A. P. Waters, and C. J. Janse. 1999. Analysis of stage specificity of promoters in Plasmodium berghei using luciferase as a reporter. Mol. Biochem. Parasitol. 100:141-146.
11. De Souza, J. B., K. H. Williamson, T. Otani, and J. H. L. Playfair. 1997. Early gamma interferon responses in lethal and nonlethal murine bloodstage malaria. Infect. Immun. 65:1593-1598.
12. Dieckmann-Schuppert, A., S. Bender, M. Odenthal-Schnittler, E. Bause, and R. T. Schwarz. 1992. Apparent lack of N-glycosylation in the asexual intraerythrocytic stage of Plasmodium falciparum. Eur. J. Biochem. 205:815-825.
13. Ealick, S. E., W. J. Cook, S. Vijay-Kumar, M. Carson, T. L. Nagabhushan, P. P. Trotta, and C. E. Bugg. 1991. Three-dimensional structure of recombinant human interferon-gamma. Science 252:698-702.
14. Ferreira, A., L. Schofield, V. Enea, H. Schellekens, P. van der Meide, W. E. Collins, R. S. Nussenzweig, and V. Nussenzweig. 1986. Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science 232:881-884.
15. Gherardi, M. M., J. C. Ramirez, D. Rodriguez, J. R. Rodriguez, G. Sano, F. Zavala, and M. Esteban. 1999. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner. J. Immunol. 162:6724-6733.
16. Giavedoni, L., S. Ahmad, L. Jones, and T. Yilma. 1997. Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques. J. Virol. 71:866-872.
17. Giavedoni, L. D., L. Jones, M. B. Gardner, H. L. Gibson, C. T. Ng, P. J. Barr, and T. Yilma. 1992. Vaccinia virus recombinants expressing chimeric proteins of human immunodeficiency virus and gamma interferon are attenuated for nude mice. Proc. Natl. Acad. Sci. USA 89:3409-3413.
18. Goonewardene, R., J. Daily, D. Kaslow, T. J. Sullivan, P. Duffy, R. Carter, K. Mendis, and D. Wirth. 1993. Transfection of the malaria parasite and expression of firefly luciferase. Proc. Natl. Acad. Sci. USA 90:5234-5236.
19. Gurunathan, S., C. Y. Wu, B. L. Freidag, and R. A. Seder. 2000. DNA vaccines: a key for inducing long-term cellular immunity. Curr. Opin. Immunol. 12:442-447.
20. Herrera, M. A., F. Rosero, S. Herrera, P. Caspers, D. Rotmann, F. Sinigaglia, and U. Certa. 1992. Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection. Infect. Immun. 60:154-158.
21. Hoffman, S. L., J. M. Crutcher, S. K. Puri, A. A. Ansari, F. Villinger, E. D. Franke, P. P. Singh, F. Finkelman, M. K. Gately, G. P. Dutta, and M. Sedegah. 1997. Sterile protection of monkeys against malaria after administration of interleukin-12, Nat. Med. 3:80-83.
22. Ijzermans, J. N., E. Bouwman, J. Jeekel, and R. L. Marquet. 1990. Donor pretreatment with IFN-gamma enhances MHC class II antigen expression and accelerates graft rejection by modified recipients. Transplant Proc. 22:1941-1942.
23. Klotz, F. W., D. E. Hudson, H. G. Coon, and L. H. Miller. 1987. Vaccination-induced variation in the 140 kD merozoite surface antigen of Plasmodium knowlesi malaria. J. Exp. Med. 165:359-367.
24. Kocken, C. H. M., H. Ozwara, A. van der Wel, A. L. Beetsma, J. M. Mwenda, and A. W. Thomas. 2002. Plasmodium knowlesi provides a.rapid in vitro and in vivo transfection system that enables double-crossover gene knockout studies. Infect. Immun. 70:655-660.
25. Kocken, C. H. M., A. M. van der Wel, M. A. Dubbeld, D. L. Narum, F. M. van de Rijke, G. J. van Gemert, X. van der Linde, L. H. Bannister, C. Janse, A. P. Waters, and A. W. Thomas. 1998. Precise timing of expression of a Plasmo·dium falciparum-derived transgene in Plasmodium berghei is a critical determinant of subsequent subcellular localization. J. Biol. Chem. 273:15119-15124.
26. Kurzrock, A., M. G. Rosenblum, S. A. Sherwin, A. Rios, M. Talpaz, J. R. Quesada, and J. U. Gutterman. 1985. Pharmacokinetics, single-dose tolerance and biological activity of recombinant γ-interferon in cancer patients. Cancer Res. 45:2666-2672.
27. Le, J., and J. Vilcek. 1984. Lymphokine-mediated activation of human monocytes: neutralization by monoclonal antibody to interferon-gamma. Cell Immunol. 85:278-283.
28. Luty, A. J., B. Lell, R. Schmidt-Ott, L. G. Lehman, D. Luckner, B. Greve, P. Matousek, K. Herbich, D. Schmid, F. Migot-Nabias, P. Deloron, R. S. Nussenzweig, and P. G. Kremsner. 1999. Interferon- gamma responses are associated with resistance to reinfection with Plasmodiam falciparum in young African children. J. Infect. Dis. 179:980-988.
29. Maheshwari, R. K., C. W. Czarniecki, G. P. Dutta, S. K. Puri, B. N. Dhawan, and R. M. Friedman. 1986. Recombinant human gamma interferon inhibits simian malaria. Infect. Immun. 53:628-630.
30. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
31. Mellouk, S., S. J. Green, C. A. Nacy, and S. L. Hoffman. 1991. IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. J. Immunol. 146:3971-3976.
32. Nardin, E. H., and R. S. Nussenzweig. 1993. T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Annu. Rev. Immunol. 11:687-727.
33. Nussler, A., J. C. Drapier, L. Renia, S. Pied, F. Miltgen, M. Gentilini, and D. Mazier. 1991. L-Arginine-dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin 6 stimulation. Eur. J. Immunol. 21:227-230.
34. Ozwara, H., H. Niphuis, L. Buijs, M. Jonker, J. L. Heeney, C. S. Bambra, A. W. Thomas, and J. A. Langermans. 1997. Flow cytometric analysis on reactivity of human T lymphocyte-specific and cytokine-receptor-specific antibodies with peripheral blood mononuclear cells of chimpanzee (Pan troglodytes), rhesus macaque (Macaca mulatta), and squirrel monkey (Saimiri sciureus). J. Med. Primatol. 26:164-171.
35. Perera, L. P., C. K. Goldman, and T. A. Waldmann. 2001. Comparative assessment of virulence of recombinant vaccinia viruses expressing IL-2 and IL-15 in immunodeficient mice. Proc. Natl. Acad. Sci. USA 98:5146-5151.
36. Sareneva, T., J. Pirhonen, K. Cantell, and I. Julkunen. 1995. N-glycosylation of human interferon-gamma: glycans at Asn-25 are critical for protease resistance. Biochem. J. 308:9-14.
37. Schofield, L., A. Ferreira, R. Altszuler, V. Nussenzweig, and R. S. Nussenzweig. 1987. Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro. J. Immunol. 139:2020-2025.
38. + T cells and antibodies required for immunity to malaria sporozoites. Nature 330:664-666.
39. Sedegah, M., F. Finkelman, and S. L. Hoffman. 1994. Interleukin 12 induction of interferon gamma-dependent protection against malaria. Proc. Natl. Acad. Sci. USA 91:10700-10702.
40. + T cells. J. Exp. Med. 180:353-358.
41. Shear, H. L., R. Srinivasan, T. Nolan, and C. Ng. 1989. Role of IFN-gamma in lethal and nonlethal malaria in susceptible and resistant murine hosts. J. Immunol. 143:2038-2044.
42. Sherman, I. W. 1985. Membrane structure and function of malaria parasites and the infected erythrocyte. Parasitology 91:609-645.
43. Steidler, L., W. Hans, L. Schotte, S. Neirynck, F. Obermeier, W. Falk, W. Fiers, and E. Remaut. 2000. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289:1352-1355.
44. Stevenson, M. M., M. F. Tam, M. Belosevic, P. H. van der Meide, and J. E. Podoba. 1990. Role of endogenous gamma interferon in host response to infection with blood-stage Plasmodium chabaudi AS. Infect. Immun. 58:3225-3232.
45. Su, Z., and M. M. Stevenson. 2000. Central role of endogenous gamma interferon in protective immunity against blood-stage Plasmodium chabaudi AS infection. Infect. Immun. 68:4399-4406.
46. Sztein, M. B., P. S. Steeg, H. M. Johnson, and J. J. Oppenheim. 1984. Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons. J. Clin. Investig. 73:556-565.
47. Tobin, J. F., S. L. Reiner, F. Hatam, S. Zheng, C. L. Leptak, D. F. Wirth, and R. M. Locksley. 1993. Transfected Leishmania expressing biologically active IFN-gamma. J. Immunol. 150:5059-5069.
48. van der Meide, P. H., M. Dubbeld, and H. Schellekens. 1985. Monoclonal antibodies to human immune interferon and their use in a sensitive solidphase ELISA. J. Immunol. Methods 79:293-305.
49. van der Wel, A. M., A. M. Tomas, C. H. Kocken, P. Malhotra, C. J. Janse, A. P. Waters, and A. W. Thomas. 1997. Transfection of the primate malaria parasite Plasmodium knowlesi using entirely heterologous constructs. J. Exp. Med. 185:1499-1503.
50. van Dijk, M. R., R. Vinkenoog, J. Ramesar, R. A. Vervenne, A. P. Waters, and C. J. Janse. 1997. Replication, expression and segregation of plasmid-borne DNA in genetically transformed malaria parasites. Mol. Biochem. Parasitol. 86:155-162.
51. van Dijk, M. R., A. P. Waters, and C. J. Janse. 1995. Stable transfection of malaria parasite blood stages. Science 268:1358-1362.
52. Villinger, F., S. S. Brar, A. Mayne, N. Chikkala, and A. A. Ansari. 1995. Comparative sequence analysis of cytokine genes from human and nonhuman primates. J. Immunol. 155:3946-3954.
53. Wong, G. H., I. Clark-Lewis, L. McKimm-Breschkin, A. W. Harris, and J. W. Schrader. 1983. Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines. J. Immunol. 131:788-793.
54. Wu, Y., C. D. Sifri, H. H. Lei, X. Z. Su, and T. E. Wellems. 1995. Transfection of Plasmodium falciparum within human red blood cells. Proc. Natl. Acad. Sci. USA 92:973-977.
55. Yoneto, T., T. Yoshimoto, C.-R. Wang, Y. Takahama, M. Tsuji, S. Waki, and H. Nariuchi. 1999. Gamma interferon production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither NO production nor NK cell activation is critical. Infect. Immun. 67:2349-2356.